![Tomotaka Okino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tomotaka Okino
Private Equity Investor bei Ono Venture Investment, Inc.
Ursprung des Netzwerks ersten Grades von Tomotaka Okino
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Ono Venture Investment, Inc.
![]() Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California.
2
| Subsidiary | Investment Managers | 2 |
Kyoto Pharmaceutical University
1
| College/University | Other Consumer Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tomotaka Okino
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Mitobridge, Inc.
![]() Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
University of Tsukuba | College/University | Doctorate Degree | |
Kyoto University | College/University | Graduate Degree | |
McGill University | College/University | Masters Business Admin | |
Potenza Therapeutics, Inc.
![]() Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Astellas Pharma US, Inc.
![]() Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Private Equity Investor | |
Ono Pharma USA, Inc.
![]() Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito. | Internet Software/Services | Private Equity Investor | |
ONO PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Private Equity Investor | |
OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Santen Pharmaceutical (China) Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
Shenyang Pharmaceutical University | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Japan | 4 |
China | 4 |
Kanada | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 5 |
Finance | 2 |
Technology Services | 2 |
Operativ
Private Equity Investor | 5 |
Director/Board Member | 3 |
Graduate Degree | 3 |
Doctorate Degree | 2 |
Masters Business Admin | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Shunichiro Matsumoto | 10 |
Zhao Peng Hu | 4 |
Hiroshi Yamamoto | 2 |
- Börse
- Insiders
- Tomotaka Okino
- Unternehmensverbindungen